Triphala, an Ayurvedic formulation improves the antioxidant status on TNBS induced IBD in rats

European Journal of Integrative Medicine

Volumn 6, Issue 6, 2014, Pages 646-656

  Koppikar, Soumya J ^a   Jagtap, Suresh D ^a   Devarshi, Prasad P ^a   Jangle, Nivedita M ^b,d   Awad, Vitthal B ^a   Wele, Asmita A ^c   Harsulkar, Abhay M ^a,b,d  

^a Bharati Vidyapeeth Deemed University   (India)

^b BHARATI VIDYAPEETH UNIVERSITY   (India)

^c BHARATI VIDYAPEETH UNIVERSITY   (India)

^d BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Antioxidant activity; Inflammatory bowel disease; ROS; TNBS; Triphala

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; AYURVEDIC DRUG; CATALASE; CURCUMIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MESALAZINE; NITRATE; NITRIC OXIDE; NITRITE; SUPEROXIDE DISMUTASE; TRINITROBENZENESULFONIC ACID; TRIPHALA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AYURVEDA; CELL INFILTRATION; COLON; CONTROLLED STUDY; DRUG FORMULATION; ENZYME ACTIVITY; HISTOPATHOLOGY; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY CELL; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; TISSUE NECROSIS;

EID: 84910137881     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2014.08.005     Document Type: Article

References (48)

1. Geboes K. Histopathology of Crohn's disease and ulcerative colitis. Inflammatory bowel disease 2003, 255-276. Churchill Livingstone, Edinburgh/London/Melbourne. J. Satsangi, L.R. Sutherland, J.F. Colombel, C. Fiocci, R. Lofberg, J. Pemberton, P. Rutgeerts (Eds.).
2. Zhu H., Li Y.R. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Exp Biol Med 2012, 237:474-480.
3. Alzoghaibi M.A. Neutrophil expression and infiltration into Crohn's intestine. Saudi J Gastroenterol 2005, 11:63-72.
4. Yang S-K., Loftus E.V., Sandborn W.J. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis 2001, 7:260-270.
5. Arias-Loste M.T., Castro B., Rivero M., Crespo J. Epidemiology of intrafamilial inflammatory bowel disease throughout Europe. Annal Gastroenterol 2012, 25:188-192.
6. Veluswamy H., Suryawala K., Sheth A., Wells S., Salvatierra E., Cromer W., et al. African-American inflammatory bowel disease in a Southern U.S. health center. BMC Gastroenterol 2010, 10:104.
7. Jagtap A.G., Shirke S.S., Phadke S. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. J Ethnopharmacol 2004, 90:195-204.
8. Kedia P., Cohen R. Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis. Ther Clin Risk Manage 2007, 3:919-927.
9. Rasool M., Sabina E.P. Antiinflammatory effect of the Indian Ayurvedic herbal formulation Triphala on adjuvant-induced arthritis in mice. Phytother Res 2007, 21:889-894.
10. Srikumar R., Parthasarathy N.J., Devi R.S. Immunomodulatory activity of Triphala on neutrophil functions. Biol Pharm Bull 2005, 28:1398-1403.
11. Naik G.H., Priyadarsini K.I., Mohan H. Free radical scavenging reactions and phytochemical analysis of Triphala, an Ayurvedic formulation. Curr Sci 2006, 90:582-586.
12. Rajan S.S., Antony S. Hypoglycemic effect of Triphala on selected non insulin dependent Diabetes mellitus subjects. Anc Sci Life 2007, 17:45-49.
13. Biradar Y.S., Jagtap S., Khandelwal K.R., Singhania S.S. Exploring of antimicrobial activity of Triphala Mashi - an Ayurvedic formulation. eCAM 2008, 5:107-113.
14. Baliga M.S. Triphala, Ayurvedic formulation for treating and preventing cancer: a review. J Altern Complement Med 2010, 16:1301-1308.
15. Jain S.K. Dictionary of Indian folk medicine and ethnobotany 1991, Deep Publications, New Delhi, India.
16. Kirtikar K.R., Basu B.D. Indian medicinal plants 1975, vol. 2:894-895. Bishen Singh Mahendra Pal Singh, Dehradun, India, International book distributor. 2nd ed.
17. Jagtap S.D., Deokule S.S., Bhosale S.V. Some unique ethnomedicinal uses of plants used by the Korku tribe of Amravati District of Maharashtra, India. J Ethnopharmacol 2006, 107:463-469.
18. Nariya M., Shukla V., Shukla V., Jain S., Ravishankar B. Comparison of enteroprotective efficacy of Triphala formulations (Indian Herbal Drug) on methotrexate-induced small intestinal damage in rats. Phytother Res 2009, 23:1092-1098.
19. Sabina E.P., Rasool M. An in vivo and in vitro potential of Indian Ayurvedic herbal formulation Triphala on experimental gouty arthritis in mice. Vascul Pharmacol 2007, 48:14-20.
20. Carroll M., Andrus J.M., Bruno-Bárcena J.M., Klaenhammer T.R., Hassan H.M., Threadgill D.S. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 2007, 293:729-738.
21. Yao L.K., Razak S.L.A., Ismail N., Fai N.C., Asgar M.H.A.M., Sharif N.M., et al. Malaysian gelam honey reduces oxidative damage and modulates antioxidant enzyme activities in young and middle aged rats. J Med Plants Res 2011, 5:5618-5625.
22. Anonymous Ayurvedic formulary of India part I 2003, Government of India, Ministry of Health and Family Welfare, Department of Indian Systems of Medicine and Homeopathy, New Delhi. 2nd ed.
23. Pawar P., Gilda S., Sharma S., Jagtap S., Paradkar A., Mahadik K., et al. Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and mucorestorative activity in TNBS-induced inflammatory bowel disease. BMC Complement Altern Med 2011, 11:34.
24. Celiński K., Dworzański T., Korolczuk A., Słomka M., Radej S., Piasecki R., et al. Comparison of main models of experimental colitis essential for studies on novel therapies of inflammatory bowel disease. Gastroenterol Pol 2010, 17:195-202.
25. Nakhai L.A., Mohammadirad A., Yasa N., Minaie B., Nikfar S., Ghazanfari G., et al. Benefits of Zataria multiflora Boiss in experimental model of mouse inflammatory bowel disease. eCAM 2007, 4:43-50.
26. Nieto N., Torres M.I., Fernández M.I., Giron M.D., Rios A., Suarez M.D., et al. Experimental Ulcerative colitis impairs antioxidant defense system in rat intestine. Dig Dis Sci 2000, 45:1820-1827.
27. Blau S., Kohen R., Bass P., Rubinstein A. Relation between colonic inflammation severity and total low-molecular-weight antioxidant profiles in experimental colitis. Dig Dis Sci 2000, 45:1180-1187.
28. Zhou Y.-H., Yu J.-P., Liu Y.-F., Teng X.-J., Ming M., Lv P., et al. Effects of Ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-α, NF-(Bp65, IL-6) in TNBS-induced colitis in rats. Mediat Inflamm 2006, 2006:1-9.
29. Loguercio C., D'Argenio G., Delle Cave M., Cosenza V., Valle N.D., Mazzacca G., et al. Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats. Dig Dis Sci 1996, 41:1204-1211.
30. Kanodia L., Borgohain M., Das S. Effect of fruit extract of Fragaria vesca L. on experimentally induced inflammatory bowel disease in albino rats. Indian J Pharmacol 2011, 43:18-21.
31. Petersson J., Schreiber O., Steege A., Patzak A., Hellsten A., Phillipson M., et al. eNOS involved in colitis-induced mucosal blood flow increase. Am J Physiol Gastrointest Liver Physiol 2007, 293:1281-1287.
32. Beltran B., Nos P., Dasi F., Iborra M., Bastida G., Martinez M., et al. Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naive and treated Crohn's disease. Inflamm Bowel Dis 2010, 16:76-86.
33. Hazra B., Sarkar R., Biswas S., Mandal N. Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis. BMC Complement Altern Med 2010, 10:20.
34. Gurudu S., Fiocchi C., Katz J.A. Inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2002, 16:77-90.
35. Grisham M.B. Oxidant and free radicals in inflammatory bowel disease. Lancet 1994, 344:859-861.
36. Calcerrada P., Peluffo G., Radi R. Nitric oxide-derived oxidants with a focus on peroxynitrite: molecular targets, cellular responses and therapeutic implications. Curr Pharm Des 2011, 17:3905-3932.
37. Laskina J.D., Heckb D.E., Laskinb D.L. Multifunctional role of nitric oxide in inflammation. Trends Endocrinol Metab 1994, 5:377-382.
38. Ebrahimzadeh M.A., Nabavi S.F., Nabavi S.M., Pourmorad F. Nitric oxide radical scavenging potential of some Elburz medicinal plants. Afr J Biotechnol 2010, 9:5212-5217.
39. Nicolson G.L., Conklin K.A. Molecular replacement for cancer metabolic and mitochondrial dysfunction, fatigue and the adverse effects of cancer therapy. Cancer Genomics Proteomics 2006, 3:159-168.
40. Kolios G., Valatas V., Ward S.G. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004, 113:427-437.
41. Kuldo J.M., Ogawara K.I., Werner N., Ásgeirsdóttir S.A., Kamps J.A.A.M., Kok R.J., et al. Molecular pathways of endothelial cell activation for (targeted) pharmacological intervention of chronic inflammatory diseases. Curr Vasc Pharmacol 2005, 3:11-39.
42. Lih-Brody L., Powell S.R., Collier K.P., Reddy G.M., Cerchia R., Kahn E., et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996, 41:2078-2086.
43. Yunus Y., Yuksel M., Berrak C. The effect of antioxidant therapy on colonic inflammation in the rat. Res Exp Med 1999, 199:101-110.
44. Bouzid D., Gargouri B., Mansour R.B., Amouri A., Tahri N., Lassoued S., et al. Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients. Saudi J Gastroenterol 2013, 19:131-135.
45. Sutton T.L., Zhao A., Madden K.B., Elfrey J.E., Tuft B.A., Sullivan C.A., et al. Anti-inflammatory mechanisms of enteric heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model. Infect Immun 2008, 76:4772-4782.
46. Chichlowski M., Westwood G.S., Abraham S.N., Hale L.P. Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice. PLoS ONE 2010, 5:1-10.
47. Davise M.G., Hagen P.O. Systemic inflammatory response syndrome. Br J Surg 1997, 84:920-935.
48. Sartor R.B. How relevant to human inflammatory bowel disease are current animal models of intestinal inflammation?. Aliment Pharmacol Ther 1997, 11. 89-87.